Szela Mary T. - 13 Feb 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
CEO and President, Director
Signature
/s/ Mary Szela
Issuer symbol
TLSI
Transactions as of
13 Feb 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2025, 15:55:07 UTC
Previous filing
15 Aug 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Szela Mary T CEO and President, Director 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela 25 Nov 2025 0001410289

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +125,000 +65% $0.000000 317,802 13 Feb 2024 Direct F1
transaction TLSI Common Stock Award $0 +125,000 +39% $0.000000 442,802 24 Nov 2025 Direct F2
transaction TLSI Common Stock Award $0 +300,000 +68% $0.000000 742,802 24 Nov 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +250,000 +19% $0.000000 1,578,182 24 Nov 2025 Common Stock 250,000 $5.55 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the granting of Performance Stock Units (PSUs) upon achieving or exceeding $50 million of revenue over any 12 consecutive calendar month period ending on or before February 28, 2027. The PSUs vest immediately upon achieving the performance requirement, subject to the continued employment through each respective vesting date.
F2 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date.
F3 Represents the granting of PSUs upon achieving or exceeding $75 million of revenue over any 12 consecutive calendar month period ending on or before December 31, 2027. 150,000 PSUs vest immediately upon achieving the performance requirement and 150,000 PSUs vest on the one-year anniversary of achieving the performance requirement, subject to the continued employment through each respective vesting date.
F4 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date.